AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer

Background: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that cannot be treated with targeted therapies such as endocrine therapy or anti-HER-2 (anti-human epidermal growth factor receptor 2) therapy. In the growth of tumors, AFF3 (AF4/FMR2 family member 3) plays a cri...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jing Chen, Bing Tan, Wei Zhuang, Tenghua Yu, Jianglong Li, Chongwu He
Format:	Artigo
Idioma:	Inglês
Publicat:	IMR Press 2023-08-01
Col·lecció:	Clinical and Experimental Obstetrics & Gynecology
Matèries:	triple-negative breast cancer aff3 the cancer genome atlas (tcga) gene expression omnibus (geo) biomarker prognosis immune cell infiltration
Accés en línia:	https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008165
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!